{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88442",
      "recalling_firm": "Teva Pharmaceuticals USA",
      "address_1": "400 Interpace Pkwy",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.",
      "recall_number": "D-0743-2021",
      "product_description": "Methylprednisolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-0051-01), and b) 5mL Multi Dose Vials (NDC 0703-0063-01),  Rx only, TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.",
      "product_quantity": "50,713 vials",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20210729",
      "center_classification_date": "20210816",
      "termination_date": "20240604",
      "report_date": "20210825",
      "code_info": "Lot #: a) 31329363B, exp. date 01/2022; 31329484B, exp. date 03/2022  b) 31328367B, 31328431B, exp. date 07/2021; 31329014B, exp. date 11/2021"
    }
  ]
}